3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
4
Head and Neck Neoplasms
3
Polycystic Ovary Syndrome
2
Neoplasms
2
Endocrine System Diseases
2
Amenorrhea
2
Trismus
1
Thrombosis
1
Pain
1
Neuroma
1
Movement Disorders
1
Motor Activity
1
Lymphedema
1
Health Education
1
Fibrosis
1
Deglutition Disorders
1
Anxiety Disorders
1
Agnosia
1
Interventions
Metformin
139
Clomiphene
44
Letrozole
36
Inositol
28
Folic Acid
17
Exercise
17
Progesterone
16
Ethinyl Estradiol
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Chorionic Gonadotropin
10
Triptorelin Pamoate
9
Tablets
9
Spironolactone
8
Diet
8
Cholecalciferol
8
Vitamin D
7
Thioctic Acid
7
Surveys and Questionnaires
7
Menotropins
7
Liraglutide
7
Gonadotropins
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Polycystic Ovary Syndrome
×
Musculoskeletal Manipulations
×
Clear all
NCT00744510
2012-12-04
REPOS
University of Nottingham
Phase 3
Unknown
140 enrolled
NCT00746148
2012-12-04
REPOS
University of Nottingham
Phase 3
Unknown
140 enrolled